<DOC>
	<DOCNO>NCT00272792</DOCNO>
	<brief_summary>The primary objective trial evaluate ability Phenoptin increase phenylalanine ( phe ) tolerance child phenylketonuria follow phe-restricted diet .</brief_summary>
	<brief_title>Study Phenoptin Increase Phenylalanine Tolerance Phenylketonuric Children Phenylalanine-restricted Diet</brief_title>
	<detailed_description />
	<mesh_term>Phenylketonurias</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Clinical diagnosis PKU hyperphenylalaninemia ( HPA ) document least one blood Phe measurement &gt; /=360 umol/L ( 6 mg/dL ) Under dietary control Pherestricted diet evidence : · Estimated daily Phe tolerance &lt; /=1000 mg/day At least 6 month blood Phe control ( mean level &lt; /=480 μmol/L ) prior enrol study Aged 4 12 year inclusive screen A blood Phe level &lt; /=480 μmol/L screen Female subject childbearing potential ( determined principal investigator ) must negative blood urine pregnancy test entry ( prior first dose ) . Note : All female subject childbearing potential sexually mature male subject must advise use medically accept method contraception throughout study . Female subject childbearing potential must willing undergo periodic pregnancy test course study Willing able comply study procedure Willing provide write assent ( applicable ) write informed consent parent legal guardian nature study explain prior researchrelated procedure Any condition , view PI , render subject high risk treatment compliance and/or complete study Prior history organ transplantation Perceived unreliable unavailable study participation parent legal guardian perceive unreliable unavailable Use investigational agent within 30 day prior screen , requirement investigational agent vaccine prior completion schedule study assessment ALT &gt; 2 time upper limit normal ( i.e. , Grade 1 high base World Health Organization Toxicity Criteria ) screen Concurrent disease condition would interfere study participation safety ( e.g. , seizure disorder , oral steroiddependent asthma condition require oral parenteral corticosteroid administration , insulindependent diabetes )</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>